首页> 外文期刊>日本腎臓学会誌 >Effect of oral intake of an enteric capsule preparation containing Bifidobacterium longum on the progression of chronic renal failure
【24h】

Effect of oral intake of an enteric capsule preparation containing Bifidobacterium longum on the progression of chronic renal failure

机译:口服含长双歧杆菌肠溶胶囊制剂对慢性肾衰竭进展的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Since the accumulation of intestinal putrefactive products, such as indole and phenol, is known to play a role in the exacerbation of chronic renal failure, reduction of these intestinal putrefactive products can be expected to retard the progression of renal failure. In the present study, an enteric capsule preparation containing Bifidobacterium longum(Bifidus HD) was administered orally to 27 patients with chronic renal failure(CRF) for 6 months. Though no significant effect was found in the whole group, a significant retardation of the progression of renal failure was found in patients with an initial serum creatinine level > or = 4.0 mg/dl or those with an initial serum inorganic phosphate level > or = 4.0 mg/dl. There was no adverse effect observed in any case. Bifidus HD is considered a useful tool for suppressing the progression of chronic renal failure(CRF) in the conservative period.
机译:由于已知肠道腐败产物如吲哚和苯酚的积累在慢性肾功能衰竭的恶化中起作用,因此可以预期这些肠道腐败产物的减少会延迟肾衰竭的进展。在本研究中,口服含长双歧杆菌(Bifidus HD)的肠溶胶囊制剂对27例慢性肾功能衰竭(CRF)患者口服了6个月。尽管在整个组中均未发现明显的疗效,但是在初始血清肌酐水平>或= 4.0 mg / dl或初始血清无机磷酸盐水平>或= 4.0的患者中发现肾功能衰竭的进展明显受阻。毫克/分升在任何情况下都没有观察到不良反应。 Bifidus HD被认为是在保守期抑制慢性肾衰竭(CRF)进展的有用工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号